New FDA approval of sIRNA therapies
Dr. Jeff Ratliff discusses FDA approval of new sIRNA therapies.
22 Elo 20192min
Continuum Pearls: Tremor
Dr. Elan Louis discusses tremor in the first part of a three-part series. To learn more, read the article "Tremor" by Dr. Louis in the August 2019 Movement Disorders issue of Continuum.
21 Elo 20191min
A new paraneoplastic biomarker
Dr. Anastasia Zekeridou discusses the main takeaways from her paper on a new paraneoplastic biomarker.
20 Elo 20191min
"Evergreen" Drug Prices
Prof. Robin Feldman discusses "evergreen" drug pricing, from her paper in the Journal of Law and the Biosciences, which you can read here: https://academic.oup.com/jlb/article/5/3/590/5232981.
19 Elo 20191min
Sex in Parkinson disease
Dr. Jill Farmer offers tips to give patients related to sex in Parkinson disease.
14 Elo 20191min
Impulse control and RBD in PD
Dr. Michele Hu and discuss the take-home message from her and Dr. David Okai's paper on a longitudinal study of the severity of impulse control disorders in Parkinson disease and RBD.
13 Elo 20191min
CRISPR babies
Dr. Heidi Ledford, senior science reporter for Nature, discusses the next steps in gene editing technology.
12 Elo 20191min
Non-motor symptoms of Parkinson disease
Dr. Jill Farmer discusses recognition and treatment of non-motor symptoms of Parkinson disease.
9 Elo 20191min
